BlackRock, Inc.

BLK Q1 2026

Reported: 2026-04-14

BlackRock delivered a strong Q1 2026 with 27% revenue growth, broad-based organic fee expansion, and record $130 billion inflows amid volatile markets. The firm’s fundamentals remain robust, with sustained momentum across key product areas.

Key takeaways

Q1 revenue rose 27% YoY to $6.7 billion, driven by organic growth, higher AUM, and acquisitions (HPS, Preqin).
Net inflows reached $130 billion, fueled primarily by ETF record inflows of $132 billion, with bond ETFs leading.
Operating margin expanded 130 basis points to 44.5%, supported by market-driven revenue growth and strong fee retention.
EPS increased 11% YoY to $12.53, reflecting operating leverage and expense management.
Ongoing share repurchase program of at least $450 million per quarter demonstrates capital discipline amidst robust growth momentum.

View recap

Citigroup Inc.

C Q1 2026

Reported: 2026-04-14

Citigroup kicks off 2026 with a record first quarter, driven by 14% revenue growth across core segments and a focus on strategic investments, capital returns, and operational efficiency.

Key takeaways

Net income reached $5.8 billion with EPS of $3.06, and ROTCE of 13.1%; strong performance across four of five core businesses.
Revenues increased 14%, led by a 40% rise in services mandates and nearly 40% equities growth; markets revenue surpassed $7 billion for the first time in a decade.
Capital management remained robust with $6.3 billion share repurchases and a CET1 ratio of 12.7%, approaching regulatory thresholds.
Business transformation advances include exiting Russia, progressing on Banamex and Poland divestitures, and accelerating AI deployment.
Despite global macro headwinds, Citi maintains resilience, targeting 10-11% ROTCE for 2026, with strategic initiatives expected to drive sustainable growth.

View recap

Johnson & Johnson

JNJ Q1 2026

Reported: 2026-04-14

Johnson & Johnson delivered a robust Q1 2026 with 6.4% operational sales growth, driven by strong performances across its innovative pharma and MedTech segments, and raised full-year guidance toward $100 billion revenue.

Key takeaways

Q1 revenue grew 6.4% annually, with Innovative Medicine up 7.4% and MedTech up 4.6%, reflecting broad-based momentum.
Oncology led with 18% growth in DARZALEX and FDA approvals for TECVAYLI and CARVYKTI, expanding pipeline impact.
Immunology sales surged 64%, driven by TREMFYA, and FDA approval of ICOTYDE positions the company for significant market share in immunology.
MedTech’s cardiovascular segment showed strength in ablation and circulatory recovery, with innovative platforms like VARIPULSE and OMNYPULSE gaining traction.
The company remains on track for $100 billion in 2026 revenue, with confidence in sustained double-digit growth through 2027.

View recap

JPMorgan Chase & Co.

JPM Q1 2026

Reported: 2026-04-14

JPMorgan Chase delivered robust Q1 2026 earnings with net income of $16.5 billion and a 10% revenue increase, supported by higher Markets activity and asset management fees despite elevated expenses and credit costs.

Key takeaways

Strong net income of $16.5 billion and EPS of $5.94, with a 23% ROTCE, reflecting solid profitability.
Revenue rose 10% year-on-year to $50.5 billion, driven by Markets, Asset & Wealth Management, and investment banking, offsetting modest rate impacts.
Expenses increased 14% to $26.9 billion, primarily due to higher compensation, brokerage, and distribution costs.
Credit costs were $2.5 billion, with net charge-offs at $2.3 billion and a small reserve build; balance sheet CET1 ratio declined modestly to 14.3%.
Ongoing regulatory proposals on Basel and G-SIB surcharges suggest higher capital requirements, potentially raising U.S. systemic impact and costs for clients over the coming years.

View recap

CarMax, Inc.

KMX Q4 2026

Reported: 2026-04-14

CarMax delivered a solid Q4 FY2026 amid strategic shifts, with operations focused on improving sales, reducing costs, and enhancing digital capabilities under new leadership.

Key takeaways

Revenues grew as efforts to lower prices, boost marketing, and deploy digital enhancements began to positively impact sales trends.
Progress was made on cost-saving initiatives, including streamlining SG&A and reducing vehicle acquisition costs to improve affordability.
Leadership transition with Keith Barr emphasizing a customer-centric approach and digital transformation to unlock growth opportunities.
The company remains focused on driving customer trust through fair pricing, broad inventory, and seamless omnichannel experiences.
Upcoming initiatives will prioritize leveraging technology for better efficiency and customer engagement, signaling a focus on long-term value creation.

View recap

Wells Fargo & Company

WFC Q1 2026

Reported: 2026-04-14

Wells Fargo delivered a solid Q1 with 15% EPS growth, driven by sustained revenue expansion and disciplined expense management amidst ongoing strategic repositioning.

Key takeaways

Revenue increased 6% year-over-year, fueled by a 5% rise in net interest income and an 8% uptick in noninterest income across all segments.
Loans grew 11%, deposits up 7%, supporting a 14% rise in pre-tax, pre-provision profit, while credit quality remains stable with a net charge-off ratio of 45 basis points.
The bank returned $5.4 billion to shareholders, including $4 billion in share repurchases, while maintaining strong excess capital.
Reached key milestone with the finalization of all 14 terminated risk and control compliance obligations since 2019, allowing a sharper focus on growth initiatives.
Momentum in retail and commercial client acquisition continues, with new account growth up nearly 60% and auto originations more than doubled, supported by digital innovations and targeted marketing.

View recap

Earnings Recaps

BlackRock, Inc.

Citigroup Inc.

Johnson & Johnson

JPMorgan Chase & Co.

CarMax, Inc.

Wells Fargo & Company

Community

Earnings Recaps

BlackRock, Inc.

Citigroup Inc.

Johnson & Johnson

JPMorgan Chase & Co.

CarMax, Inc.

Wells Fargo & Company

Community

Trending This Week

Notifications